rewiring the code of life

Next-generation regenerative medicine.

Nanotechnologies and bioactives that make the body's own regenerative machinery do the work.

Programs

Therapeutic Focus

01

Dormant Cell Reactivation

Reawakening quiescent progenitor populations already present in tissue through targeted pathway engagement. Our programs restore the body's own regenerative signaling without introducing exogenous cells.

02

Tissue Repair & Wound Biology

Accelerating native tissue remodeling through receptor-mediated activation of the body's structural repair cascades. Programs span chronic wound environments and extracellular matrix restoration.

03

Regenerative Reprogramming

Modulating cellular bioenergetics to reverse dormancy in aged or senescent tissue. Early-stage programs are exploring multi-pathway approaches to re-engage endogenous regenerative capacity at the metabolic level.

ARCIS Engine

Computational Discovery Engine

A machine learning and in silico modeling platform built to predict, validate, and optimize bioactive-target interactions before entering the wet lab. Reducing time-to-candidate through structure-guided computational biology.

› Structure-based molecular docking informed by deep learning protein structure prediction
› Physiologically-based pharmacokinetic (PBPK) modeling with population-level Monte Carlo simulation
› In silico ADMET prediction and multi-parameter optimization across candidate libraries
› Receptor-ligand binding affinity scoring with ensemble machine learning classifiers
› Multi-target pathway network analysis with sensitivity-driven prioritization
Simulation Before Synthesis

Every candidate is computationally validated across binding, pharmacokinetics, and safety parameters in silico. High-confidence predictions that de-risk wet-lab studies and accelerate regulatory-ready data packages.